People · Operator

Brian E. Schnieders

Named in public records as an officer, director or promoter · active 2010–2014 · Pharmaceuticals

1
Companies
6
Filings
$115.9M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Romark Laboratories, L.C.PharmaceuticalsSeries B$115.9M$365.5M2010
Operator network

Brian E. Schnieders at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

W. Andrew Krusen, Jr. · 4 companies · 1 sharedW. Andrew Krusen,…Brian S. Schnieders · 2 companies · 1 sharedBrian S. Schniede…Celine S. Rossignol · 2 companies · 1 sharedCeline S. Rossign…Marc S. Ayers · 2 companies · 1 sharedMarc S. AyersW. Seymour Holt · 2 companies · 1 sharedW. Seymour HoltBrian Schnieders · 1 companies · 1 sharedBrian SchniedersCeline E. Rossignol · 1 companies · 1 sharedCeline E. Rossign…Celine Rossignol · 1 companies · 1 sharedCeline RossignolEmmet B. Keefe · 1 companies · 1 sharedEmmet B. KeefeJean Francois Rossignol · 1 companies · 1 sharedJean Francois Ros…Jeff B. Crowther · 1 companies · 1 sharedJeff B. CrowtherJeff Crowther · 1 companies · 1 sharedJeff CrowtherKurt Andrew Frahn · 1 companies · 1 sharedKurt Andrew FrahnRomark Laboratories, L.C. · $115.9M raisedRomark Laboratories, …Brian E. SchniedersBS
Brian E. Schnieders Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Brian E. Schnieders on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
W. Andrew Krusen, Jr.14
W. Seymour Holt12
Celine S. Rossignol12
Marc S. Ayers12
Brian S. Schnieders12
Celine Rossignol11
Jeff Crowther11
Jeff B. Crowther11
Brian Schnieders11
Emmet B. Keefe11
Jean Francois Rossignol11
Celine E. Rossignol11
Kurt Andrew Frahn11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.